Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 30, 2025
miRecule and GBI Biomanufacturing announced a strategic partnership to advance the development and clinical supply of miRecule's innovative Antibody-RNA Conjugate (ARC) based products.
read more
Hovione announced that Dr. Jean Luc Herbeaux has decided to step down from his role as Chief Executive Officer for personal reasons, effective as of May 21, 2026. To facilitate a smooth transition, Dr. Herbeaux will continue with the company until ...
read more
WASHINGTON (AP) — The drug industry's decade-spanning search for a female equivalent to Viagra took a major step forward Thursday, as government experts recommended approval for a pill to boost sexual desire in women.
read more
Thursday, October 12, 2017
SGS has entered into collaboration with Bavarian Nordic A/S, an international biotechnology company specializing in vaccines, to develop a new respiratory syncytial virus (RSV) challenge strain.
read more
Adare Pharma Solutions announced it is further investing in its Pessano facility in Milan, Italy, with the addition of a high-shear mixer granulator to complement existing fluid bed capabilities.
read more
PCM Trials, and its subsidiaries EmVenio Research and Clinical Trial Service, are aligning under a single name – EmVenio Clinical Research. This consolidation brings together each company’s strengths under one entity to offer sponsors and contract ...
read more
Out of an abundance of caution, and with a rapidly growing number of our participants not being able to travel, we’ve made the difficult decision to cancel DCAT Week 2020.
read more
Trxade announced that its Bonum Health subsidiary has launched a B2B platform which bundles telehealth, a COVID-19 risk assessment tool and a PPE purchasing tool, through a secure mobile dashboard for corporate clients.
read more
Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, announced the appointment of Nick Foster as Chief Commercial Officer and Head of Global Business Development, to support the broadening of Metrion’s...
read more
Wednesday, March 02, 2016
WuXi Biologics Co. and Prima BioMed Ltd. have announced that through their strategic supply partnership, Prima's first-in-class immuno-oncology product candidate IMP321 (LAG-3 Ig fusion protein), manufactured at WuXi's state-of-the-art cGMP facility ...
read more
Tuesday, October 03, 2023
Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic peptides with multi-kilogram GMP facilities and fill-finish capabilities designed to support ...
read more
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has contributed biopharmaceutical manufacturing ontologies to The Open Applications Group (OAGi) for further development as an open-source project. Shifting NIIMBL's ...
read more
Sharp Packaging Solutions has increased its packaging capacity by 30% for its life science customers with a $45 million investment in a new Center of Excellence for specialty/biologic/cold chain packaging on Penn Am Drive, Allentown and in the ...
read more
Tuesday, September 16, 2025
Sharp Services announced a $20M investment in its autoinjector and pen assembly, labeling and packaging lines across various therapeutic areas at its facility in Macungie, PA.
read more
Monday, February 01, 2016
WAVE Life Sciences Ltd., a genetic medicine company focused on advancing potential best-in-class stereopure nucleic acid therapies, has announced its plan to deliver six clinical programs by 2018.
read more